Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Grey

Showing results (21-30 of 256) with videos related to

Pageof 26
Sort By:
Clinical Endocrinology|January 30, 2023
Increased workload without clinical benefit: Results following implementation of the ACR-TIRADS system for thyroid nodulesMark J Bolland, Andrew Grey
Annals of Internal Medicine|April 18, 2022
Nonoperative Management of Mild Primary Hyperparathyroidism: A Reasonable, Evidence-Based OptionMark J Bolland, Andrew Grey
The New Zealand Medical Journal|October 6, 2022
Is PHARMAC's decision-making fair, cost-effective and clinically effective? Observations from the real worldMark J Bolland, Andrew Grey
The American Journal of Medicine|January 28, 2010
Benefits of vitamin d?Mark J Bolland, Andrew Grey
BMJ Open|October 9, 2014
A comparison of adverse event and fracture efficacy data for strontium ranelate in regulatory documents and the publication recordMark J Bolland, Andrew Grey
Expert Opinion on Investigational Drugs|April 19, 2005
Emerging and potential therapies for osteoporosisAndrew Grey, Ian R Reid
Clinical Endocrinology|June 27, 2013
Nonsustained hypercalcaemia and primary hyperparathyroidism in the PEARS cohortMark J Bolland, Andrew Grey
Clinical Endocrinology|April 28, 2011
Management of primary hyperparathyroidismAndrew Grey, Mark J Bolland
Clinical Endocrinology|March 28, 2021
Decreased thyroid FNA but increased ultrasound: Is the trade-off worthwhile?Mark J Bolland, Andrew Grey
Plos One|January 1, 2015
A case study of discordant overlapping meta-analyses: vitamin d supplements and fractureMark J Bolland, Andrew Grey
Pageof 26

Showing results (21-30 of 256) with videos related to

Sort By:
Pageof 26
Clinical Endocrinology|January 30, 2023
Increased workload without clinical benefit: Results following implementation of the ACR-TIRADS system for thyroid nodulesMark J Bolland, Andrew Grey
Annals of Internal Medicine|April 18, 2022
Nonoperative Management of Mild Primary Hyperparathyroidism: A Reasonable, Evidence-Based OptionMark J Bolland, Andrew Grey
The New Zealand Medical Journal|October 6, 2022
Is PHARMAC's decision-making fair, cost-effective and clinically effective? Observations from the real worldMark J Bolland, Andrew Grey
The American Journal of Medicine|January 28, 2010
Benefits of vitamin d?Mark J Bolland, Andrew Grey
BMJ Open|October 9, 2014
A comparison of adverse event and fracture efficacy data for strontium ranelate in regulatory documents and the publication recordMark J Bolland, Andrew Grey
Expert Opinion on Investigational Drugs|April 19, 2005
Emerging and potential therapies for osteoporosisAndrew Grey, Ian R Reid
Clinical Endocrinology|June 27, 2013
Nonsustained hypercalcaemia and primary hyperparathyroidism in the PEARS cohortMark J Bolland, Andrew Grey
Clinical Endocrinology|April 28, 2011
Management of primary hyperparathyroidismAndrew Grey, Mark J Bolland
Clinical Endocrinology|March 28, 2021
Decreased thyroid FNA but increased ultrasound: Is the trade-off worthwhile?Mark J Bolland, Andrew Grey
Plos One|January 1, 2015
A case study of discordant overlapping meta-analyses: vitamin d supplements and fractureMark J Bolland, Andrew Grey
Pageof 26